login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ANEBULO PHARMACEUTICALS INC (ANEB) Stock News
USA
- NASDAQ:ANEB -
US0345691036
-
Common Stock
2.47
USD
-0.03 (-1.2%)
Last: 9/18/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ANEB Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Chartmill
- Mentions:
FARM
RENT
HSDT
OPI
...
Which stocks are gapping on Friday?
7 days ago - By: Chartmill
- Mentions:
FARM
RENT
FEIM
RH
...
Top movers in Friday's pre-market session
7 days ago - By: Benzinga
- Mentions:
GRI
IVA
COCP
ADXN
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
7 days ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives
2 months ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock
4 months ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates
7 months ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
9 months ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
10 months ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
a year ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
a year ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
a year ago - By: Lifecore Biomedical, Inc.
- Mentions:
LFCR
LGND
QLGN
Lifecore Biomedical Announces Cooperation Agreement with 22NW
a year ago - By: InvestorPlace
ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024
a year ago - By: BusinessInsider
ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024
a year ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
2 years ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates
2 years ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates
2 years ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors
2 years ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Announces New CEO
2 years ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
2 years ago - By: Benzinga
Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says
2 years ago - By: Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences
Please enable JavaScript to continue using this application.